货号 | HB996026 |
---|---|
品牌 | abinScience |
种属反应性 | Human |
应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
宿主 | Humanized |
同种型 | IgG1-kappa |
表达系统 | Mammalian Cells |
克隆类型 | Monoclonal |
靶标 | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4 |
内毒素水平 | Please contact the lab for this information. |
纯度 | >95% purity as determined by SDS-PAGE. |
纯化方式 | Protein A/G purified from cell culture supernatant. |
Accession号 | P15391 |
状态 | Liquid |
保存溶液 | 0.01M PBS, pH 7.4. |
稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
别名 | CD19, MEDI-551, 1299440-37-1 |
背景 | Budoprutug is an anti-CD19 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001). • An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer., PMID:30680780 • CAR-T cell therapy., PMID:32586666 • A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases., PMID:37427592 • B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody., PMID:20605905 • Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials., PMID:34310745 • CD19-CAR trials., PMID:24667955 • Optimized CD19/CD22/CD3 antibody., PMID:36264591 • [Not Available]., PMID:30686355 • Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma., PMID:33035333 • Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells., PMID:30030295 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
SEC-HPLC detection for Research Grade Inebilizumab.
24小时产品查询
扫一扫关注我们
专属渠道经理